formally known as gpha

Same medicine. Same results.
Lower cost.


2017 AAM (formerly GPhA) Regular Members include:

  • 3M Health Care Business
  • Accord Healthcare Inc.
  • Alvogen Inc.
  • Amneal Pharmaceuticals
  • Apotex Corporation
  • Aurobindo Pharma US
  • Baxter Healthcare Corporation
  • Cipla USA, Inc.
  • Claris Lifesciences, Inc.
  • Dr. Reddy's Laboratories Inc.
  • Fresenius-Kabi, USA LLC
  • Glenmark Pharmaceuticals, Inc., USA
  • Luitpold Pharmaceuticals, Inc.
  • Lupin Pharmaceuticals, Inc.
  • Mayne Pharma Group, Limited
  • Momenta Pharmaceuticals, Inc.
  • Mylan, N. V.
  • Sagent Pharmaceuticals, Inc.
  • Sandoz Inc., a Novartis Division
  • Sun Pharmaceutical Industries, Inc.
  • Teva Pharmaceuticals USA
  • West-Ward Pharmaceuticals - a Hikma Company
  • Zydus Pharmaceuticals USA

Join GPhA: Membership in the Generic Pharmaceutical Association gives your organization an unequaled opportunity to invest in the future of the generic industry and America’s health care system. By working together, we can make American healthcare more affordable and improve lives for less.

Types of Membership: GPhA extends two types of membership. Regular Members are corporations, partnerships or other legal entities whose primary U.S. business derives the majority of its revenues from sales of (1) finished dose drugs approved via ANDAs; (2) products sold as authorized generic drugs; (3) biosimilar/biogeneric products; or (4) DESI products. Associate Members are entities, other than Regular Members, who are allied with the interests, needs and policy positions of the generic pharmaceutical industry; including, but is not limited to: API suppliers, contract research organizations, distributors, pharmacy benefit managers, consultants, laboratories, packagers, legal counsel groups and pharmaceutical brokers.

Who are Members? GPhA member companies supply approximately 90 percent of the generic prescription drugs dispensed in the U.S. each year. Our membership includes the world’s largest generic finished dose manufacturers and active pharmaceutical ingredient suppliers. Distributors, pharmacy benefit managers, contract research organizations, packagers, and legal counsel groups also benefit from the value of belonging to GPhA.

Why Should My Company Join? GPhA is the nation’s leading trade association for manufacturers and distributors of generic prescription drugs, manufacturers of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. GPhA is a strong voice in advocating the interests of its member companies before federal and state lawmakers, regulatory policymakers, and international agencies. GPhA’s mission is to create and maintain a political and regulatory climate that is most conducive to the continued growth of our member companies.

By becoming part of GPhA, you can participate in shaping the policies that govern the generic industry and help secure the future of this vital pharmaceutical market segment. In addition, GPhA provides valuable membership services, such as business networking opportunities, educational forums, access to lawmakers and regulators, and peer-to-peer connections.

Take Advantage of Your GPhA Member Benefits

As a GPhA member, you will have a unique opportunity to steer the direction of the Association by participating on policy committees and at Board of Directors meetings, interfacing with Food and Drug Administration (FDA) officials or networking with your industry peers. You’ll also receive timely updates on the news and issues that could affect your company’s bottom line.

The following benefits are available to regular members who are in good standing with the Association.

GPhA Committees, Task Forces and Working Groups

  • Audit & Finance Committee
  • Governance Committee
  • Government Affairs Committee
  • International Affairs Working Group
  • Legal Affairs Committee
  • Media Working Group
  • Membership Advisory Committee
  • Reimbursement Working Group
  • Science and Regulatory Advisory Committee Small and Midsized Company Committee
  • State Affairs Committee

Biosimilars Council Committees 

  • Education/Strategic Partnerships Committee
  • Government Affairs Committee
  • Legal/IP Committee
  • Regulatory Committee
  • Reimbursement Committee

News and Publications

  • E-Digest. Every weekday morning in your e-mail inbox, you’ll receive a summary of the news affecting the generic pharmaceutical industry. Each news summary includes Web links to relevant articles and additional information.

  • GPhA Weekly. This weekly Capitol Hill briefing - exclusively for GPhA members summarizes - the Association’s efforts in state and federal governments.

  • Issue Briefs and Policy Papers. When there is news you need to know immediately, we create issue briefs and policy papers on hot industry topics.

  • Annual Report. You’ll receive GPhA’s Annual Report that includes an assessment of the past year and lays out the industry’s top opportunities and challenges for the year ahead.

  • Annual Generic Drugs Saving Study. The IMS Institute for Healthcare Informatics, a division of IMS Health, conducts an independent analysis showing the savings to consumers and the U.S. health care system from the use of generic prescription drugs. The IMS Institute for Healthcare Informatics has been a leading provider of market intelligence to the health care industry for more than 55 years.

Conferences and Meetings

  • Meetings and Conferences. As a GPhA member, you will receive special discounts or complimentary registrations to the Association’s cutting-edge workshops and conferences, featuring high-ranking administration officials, senior FDA staff, members of Congress, and industry leaders.

  • Networking Opportunities. Not only will you have the opportunity to meet with your industry peers at events throughout the year, you also can reach out to those peers through special access to GPhA’s membership list.

Start by calling GPhA at 202-249-7100 and ask about the membership process and corporate benefits.